Clomiphene QB Tue, 14 Mar 2023 04:40:08 +0000 en-US hourly 1 Clomiphene QB 32 32 Kosmik Brands — Greenway Magazine Wed, 29 Jun 2022 16:15:05 +0000

2021 has been an exciting year for cannabis nationwide, but in Missouri, 2021 has been the first full year open for business for the state’s medical marijuana industry. With more opportunity and expansion, operators and brands are getting bigger than ever. In this spirit, Greenway has compiled a list of brands to watch for 2022. From local talent and design to overseas players looking to make a big impact, these are the brands to know about in 2022.

Kosmik Brands has become one of Oklahoma’s most popular edibles brands, and for good reason. With quality products, dosages suitable for all consumers and a genuinely fun and attractive brand image, Kosmik leaves an impression wherever it is.

The company brings a party atmosphere to the Missouri medical marijuana space by blending a wellness product and approach to wellness with a responsible and balanced approach to dosing. For patients and consumers in Missouri, the massive 100mg Black Hole gummies allow users with high tolerances or in need of severe relief to self-medicate without having to ingest an entire bar of chocolate or a bag of gummies. Although such high doses are not suitable for everyone, the company offers several offers suitable for each consumer.

Greenway recently spoke to Kosmik CMO Cari Carmona about what the brand has in store for the state of Missouri and what makes Kosmik unique in a crowded space.

Komet the astronaut has become an iconic part of Kosmik’s brand and identity | Kosmic

“Kosmik Brands landed on Earth in 2019 with a candy that defied gravity and transcended its competition. Since day one, we’ve remained committed to taste, texture, potency and quality, and since then we’ve led the industry in innovation and developing products that push the limits. limits, and we’re just getting started. Buckle up for takeoff.

“Our mission is in the name. We focus on taste, texture, potency and quality. »

Kosmic has been a visible brand for a few years in Oklahoma and is starting well in Missouri, what changes have you had to make to adapt to Missouri?

Coming to Missouri, we had to rethink our traditional fruit bags and came up with amazing designs that still reflect the same great taste of gummies. We believe edibles should take you on a journey beyond this planet, and Missourians have embraced our brand since day one of their arrival. Needless to say, our Kosmik team takes great pride in serving our Midwestern neighbors.

At 1000mg per bag and 100mg per piece, Black Hole Cannabis Gum offers consumers a powerfully flavorful delivery form | Kosmic

What values ​​or ideas Kosmic represent?

Above all, we represent medical patients who need clean alternative medicine. As pioneers of high-dose edibles, we’re thrilled to announce that Missouri will be the very first state to offer our Black Hole gum at 100mg per piece outside of Oklahoma.

[ad_2]Source link

GadCapital: The best healthcare exchange-traded funds (ETFs) include leading biotechnology, pharmaceutical, and medical funds. Fri, 27 May 2022 11:44:58 +0000 It’s a simple method to invest in the healthcare market without having to undertake all the effort of evaluating specific firms if you’re interested in doing so. A healthcare ETF allows you to invest in a wide range of companies in the sector, as well as the ability to break it down into smaller sub-industries. ( )

However, you can choose the stock portfolio that best suits your needs. Additionally, you may reduce your exposure to market volatility by investing in an ETF rather than picking equities one at a time.

As a result, the healthcare industry has a lot of room to expand. Medicine faces a slew of ailments it must combat as individuals live longer than they ever have before, including cancer, heart disease, Alzheimer’s disease, stroke, and many more. 

Emerging illnesses like COVID-19 and disorders that have yet to be discovered are included. There’s also been a long-term increase in healthcare expenditure in the United States. 

As a result, a healthcare ETF may be a viable option for investors looking to diversify their portfolios. However, the most significant investments for beginners also include a wide range of possibilities for investors of all levels.

Which healthcare ETFs are the most common?

In the healthcare industry, several subsectors may be divided based on the kind of firms that operate inside it. You may invest in a healthcare exchange-traded fund (ETF) to get exposure to these areas.

  • This category encompasses the several sub-sectors of healthcare described below, allowing you to get a broad understanding of the field.
  • These firms are involved in biotechnology and other pharmaceuticals. I think it’s an attractive area with the potential for big profits.
  • Medical devices, such as implants or other equipment, are the primary emphasis in this sub-sector.
  • Companies that offer direct patient care are included in this industry’s healthcare providers subsector.
  • It covers firms that create conventional pharmaceuticals rather than biotech companies.

As a result, you have a wide range of alternatives. On the other hand, the broad healthcare ETF covers a wide range of healthcare-related stocks.

Looking for an ETF’s characteristics

It’s a good idea to look at a few elements of each ETF before deciding which one to invest in. It is essential to keep an eye out for the following:

  • Depending on the industry, each subsector may react differently. Because they are funded in various ways, pharmaceutical corporations and healthcare providers, for example, respond quite differently to changes in the business. As a result, you must first decide on the kind of business you wish to own.
  • In addition, you’ll want to discover the ETF’s investing track record. The industry, or has it fared better than expected in times of strength? You may get a sense of what to anticipate from the ETF based on its previous performance.
  • You should also keep an eye on the fund’s expense ratio, which informs you how much it costs to own the fund each year as a percentage of your investment in it.

According to GADCapital 60 minutes loan expert, it’s worth mentioning that bigger ETFs often have lower expense ratios since they can spread the expenses of administering the fund across a more significant number of assets. As a result, low-cost ratios are an essential indicator of an ETF’s quality. The cheapest funds may also be the biggest.

Listed below are some of the top healthcare-related exchange-traded funds (ETFs).

1. One of the best broad-based ETFs in the healthcare sector

Selected-Sector SPDR Fund for Health Care (XLV)

S&P 500 healthcare businesses are included in this exchange-traded fund mimics the Health Care Select Sector index. There are pharmaceuticals, biotechnology, and other healthcare-related companies on this index.

  • Annualized returns over the last five years: 14.0 percent (as of Sept. 30, 2021)
  • Its cost-to-income ratio is 0.12%.
  • There is a dividend yield of 1.4%

2. The iShares Nasdaq Biotechnology ETF is the best biotech ETF (IBB)

The principal holdings of this fund are Amgen, Gilead Sciences, and Moderna, and it follows an index of NASDAQ-listed biotech and pharmaceutical firms.

  • Annualized returns over the last five years: 11.1 percent (as of Sept. 30, 2021)
  • There is a 0.45% cost-to-income ratio
  • The dividend yield is 0.02%

3. ETF shares US Medical Devices ETF is the best in this category (IHI)

Abbott Laboratories and Thermo Fisher Scientific are among the firms that make up this ETF’s index.

  • Annualized returns over the last five years: 21.4 percent (as of Sept. 30, 2021)
  • Cost-to-income proportion: 41%
  • Yield: 0.2 per cent

4. The iShares U.S. Healthcare Providers ETF is the best healthcare provider ETF available today. (IHF)

UnitedHealth, CVS Health, and Cigna are the healthcare companies that this fund monitors.

  • Annualized returns over the last five years: 17.0 percent (as of Sept. 30, 2021)
  • The expense to revenue ratio: 42%
  • a 0.5 percent return on investment

5. One of the best pharma ETFs is iShares US Pharma ETF (IXPH) (IHE)

Johnson & Johnson, Pfizer, and Merck are included in this ETF’s index of US-listed pharmaceutical firms.

  • Annualized return over five years: 5.6 percent (as of Sept. 30, 2021)
  • The expense to revenue ratio: 42%
  • A 1.3 percent dividend yield.

The Bottom Line

It depends on the sub-sector you want your money tied to if you want exposure to the healthcare industry. If you don’t know which company to invest in, you may invest in an ETF covering the whole sector. The S&P 500 index ETF is an excellent example of a widely diversified index fund that doesn’t need much knowledge on the part of the investor to be successful.

Plastic Medicine Bottles Market | Analysis, Brands, Production Growth, Benefits and Overview by Major Manufacturers 2031 Wed, 27 Apr 2022 07:38:27 +0000 [ad_1]

Plastic medicine bottles are rigid packaging solutions specifically used for liquid and solid medicine packaging. Using plastic materials for manufacturing plastic medicine bottles is the main way to ensure that the packaging solution is fit for purpose. Plastic medicine bottles are used to package medical products in a way that protects them from contamination and maintains their effectiveness. The first type of packaging in the plastic medicine bottle market are liquid bottles, dropper bottles. Among all these, packaging bottles are enjoying a large demand across the world. Additionally, the demand for reliable, safe and protective packaging solutions for drug storage is driving the market growth. The rapidly growing pharmaceutical industry coupled with an increase in the number of manufacturers and high consumer focus on healthcare is accelerating the growth of plastic medicine bottles market. In addition, the global plastic medicine bottles market is expected to register significant growth, owing to the high growth in healthcare expenditure.

Get a PDF brochure @

Plastic Medicine Bottle Market: Dynamics

The global plastic medicine bottles market is expected to register significant growth, owing to the growing demand for contamination-free packaging associated with the growth of the pharmaceutical industry, especially in developing countries. Additionally, the innovation of new packaging technologies is one of the factors driving the growth of the plastic medicine bottles market. Plastic medicine bottles are lightweight, saving 20-25% on medicine packaging. Hence, these factors are believed to favor the upward growth of the target market.

Another amazing factor of plastic medicine bottles is the development of plastic medicine bottles with better barrier and aesthetic properties which are increasingly preferred by manufacturers as well as consumers. Additionally, value-added closures with child-resistant and tamper-evident features of plastic medicine bottles are likely to gain prominence in the near future and will generate significant demand.

The COVID-19 pandemic has disrupted several industries, resulting in a disrupted production process and labor shortage. However, one industry that has not been affected during the pandemic is the pharmaceutical industry due to the huge supply of essential goods and medicines which has fostered the demand for plastic medicine bottles, which is expected to drive the growth. of the target market.

Nevertheless, growing concerns over the use of single-use plastic due to its negative impact on the environment is reducing the usage of plastic medicine bottles, which may limit the growth of the target market.

Get a personalized report @

Plastic Medicine Bottle Market: Key Players

Some of the major plastic medicine bottle manufacturers operating in the market are-

Global Players:

Gerresheimer AG, RAEPAK Ltd, Röchling SE & Co. KG, Berry Global Inc. CL Smith, O.BERK®, ALPHA PACKAGING, Alpack, Inc., Pro-Pac Packaging Limited, Drug Plastics Group, Weener Plastics Group BV and others.

Plastic Medicine Bottle Market: Regional Outlook

Several major key players are dominating the global market through the development of innovative packaging solutions in the pharmaceutical sector that augment the growth of the target market. The North America & Europe region is estimated to generate substantial demand for plastic medicine bottles for the next decade due to rapidly increasing personal and healthcare expenditures by consumers and favorable state policies that have supported the plastic medicine bottles market growth. The Asia-Pacific region is expected to drive the growth due to growing demand for drugs and increasing pharmaceutical drug manufacturing activities. Moreover, in terms of market share and growth, Latin America is expected to register growth and follow the footprint of North America in the coming years.

How the plastic medicine bottle market will recover after covid19

About Us

Transparency Market Research is a next-generation market intelligence provider, delivering evidence-based solutions to business leaders, consultants, and strategy professionals.

Our reports are one-stop solutions for businesses to grow, evolve and mature. Our real-time data collection methods as well as our ability to track over a million high-growth niche products are aligned with your goals. The detailed and proprietary statistical models used by our analysts provide information to make the right decision in the shortest possible time. For organizations that need specific but comprehensive information, we offer customized solutions through ad hoc reports. These applications are delivered with the perfect combination of common sense, fact-driven problem-solving methodologies and leveraging existing data repositories.

TMR believes that the unison of solutions to customer-specific problems with the right research methodology is the key to helping companies make the right decision.


90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

E-mail: [email protected]


Source link

Leonard Rosen, Fairfax OB-GYN, convicted of prescription fraud. Fri, 18 Mar 2022 16:32:48 +0000 [ad_1]

But last year he abruptly retired and closed his practice – months before admitting in federal court in Alexandria that he had participated in a fraudulent scheme by prescribing expensive scar creams in exchange for bribes – de-wine.

He earned around $100,000 in bribes. Rosen also billed some patients as an out-of-network provider while part of their insurance network, earning approximately $52,839. He lost his ability to practice medicine and agreed to pay $1.3 million in restitution for money overpaid by insurance companies.

In court on Friday, Rosen, 72, called the crime a “significant lack of judgment” and apologized to family, friends and patients. He was sentenced to two years probation, including six months house arrest.

“This is a sad case because Dr. Rosen is obviously a fantastic doctor, and he was unfortunately drawn into a scheme that was not of his own initiative,” defense attorney Stuart Sears said. . “Given the potential results, I was pleased with the court’s decision today and the fact that the government finally agreed that incarceration was not appropriate.”

Sears said in court that Rosen “probably saved insurance companies millions of dollars because of the advances he made in robotics.” He said Rosen avoided prescribing opioids and switched to pain creams because of his concerns about addiction and abuse.

“Several times I watched him provide free health care to women who had no health insurance or financial means to pay for the visit or treatment they needed,” wrote a former nurse at the practice.

Rosen was a small player in a massive $8 million conspiracy based on doctors prescribing expensive drugs through pharmacists who paid bribes to fill orders.

According to court records, the scheme was started by two other doctors, only one of whom was charged with a crime.

It was a colleague of Rosen’s who approached pharmacist Mohamed Abdalla to accept bribes and reaped the bulk of the profits from the scheme, according to the court filing. This doctor has not been charged. Rosen said he was first told Abdalla was paying him to attend a “speakers bureau.” He said he quickly learned the truth but continued to take the money. In exchange, he began prescribing scar cream to all of his surgical patients. Before, he had only prescribed the cream to certain people.

Abdalla, who ran several pharmacies across Northern Virginia, says he began taking bribes at the suggestion of another doctor in 2013. That doctor, Arlington orthopedic surgeon Thomas Raley , pleaded guilty to fraud last year and is due to be sentenced in June. Raley’s business partner also pleaded guilty, along with a pharmaceutical salesman, another pharmacist and two pharmacy technicians.

“I succumbed to the enormous pressure and expense of owning and running a small business, which has failed me as a professional and a respected member of society for the past few years. working as a pharmacist,” Abdalla said during his sentencing. “It was my greed, one of the deadliest sins, that led me down this terrible path.”

Raley took bribes from Abdalla and others in exchange for writing prescriptions and using certain medical equipment, according to the court filing. He admitted to having set up a similar agreement with pharmacies in Maryland and Las Vegas. He specifically targeted prescriptions for the Department of Defense’s Tricare health insurance program, knowing it tended to be the most generous. He wrote prescriptions for compound drugs, which are tailored to each patient and therefore more expensive than standard drugs.

Others involved also engaged in their own tangential schemes, according to court records. Other employees in Rosen’s office prescribed Alaskan red algae powder, an expensive ingredient with uncertain benefits, in return for bribes.

A colleague of Abdalla’s who pleaded guilty said in a filing that his mentor told him such “business dealings” were a “normal” part of the job. Abdalla’s lawyer called the crime “consistent with the all-too-common practice of recruiting pharmacists to pay bribes on prescriptions.”

Fraud accounts for somewhere between 3 and 10 percent of annual health care spending in the United States, according to the National Health Care Anti-Fraud Association, a partnership between law enforcement and insurance companies. A 2019 ProPublica investigation found that healthcare fraud is rarely prosecuted when government programs are not involved.

Source link

Florida oncologist charged with prescription and insurance fraud Tue, 04 Jan 2022 17:41:06 +0000 [ad_1]

A prominent Florida oncologist was arrested last month and some in the medical community are puzzled.

Michael Dattoli, MD, radiation oncologist and chief medical officer at Dattoli Cancer Center in Sarasota, Fla., Has been charged with prescription and insurance fraud, according to the Sarasota County Sheriff’s Office.

The charges include three counts of fraudulent possession of a controlled substance, three counts of criminal use of personal identification information and three counts of insurance fraud.

Dattoli was arrested on December 16.

According to investigators, a former Dattoli Cancer Center employee alleged that Dattoli filled prescriptions for diazepam (Valium) three times on behalf of his wife using information from another health care provider.

Some experts find it strange that a doctor of his stature would eventually indulge in such a transgression – a relatively minor fraud with serious consequences.

“He’s a well-respected doctor who’s done a lot of good in the community, and it just doesn’t make sense,” said Jay Wolfson, PhD, JD, professor emeritus of public health medicine and pharmacy and vice president associate. for Health, Policy, and Safety Law at the University of South Florida, Tampa. “It’s low level fraud, and not like he’s laundering money or being involved in pill mills, which has been problematic in Florida.”

According to recent reports from local news agencies, in August 2021, Sarasota Police contacted investigators from the Sarasota County Sheriff’s Office Pharmaceutical Diversion Unit regarding a prescription fraud dating back to 2019 and 2020 involving Dattoli and a “victim”.

The victim, a former employee of the Dattoli Cancer Center, had quit his job at the end of 2020 after 5 years. His name and position at the cancer center were redacted in the arrest warrant, but the warrant mentions that he treated patients while he worked at the center.

The former employee told police that when checking the Florida prescription drug database for controlled substances in September 2021, he noticed that several fraudulent prescriptions for diazepam – a controlled substance – had been seized. from 2020. The recipient was Dattoli’s wife Rita Beatrice Dattoli, but the former employee said he never authorized these prescriptions and Dattoli’s wife had never been his patient.

In September 2021, police obtained copies of several prescriptions from local pharmacies that were called up throughout 2020 by the Dattoli Cancer Center. The prescriptions were filled and collected the same day by Dattoli himself, whose identity had been verified by his driver’s license.

Dattoli’s wife, who was questioned by police in October 2021, said she had never been a patient at the center, the order was not hers, and she never had used the prescribed medication.

A month later, Sarasota Police subpoenaed bank statements that matched accounts owned by Dattoli, which showed the same dates, the same total purchase price, and the same stores where fraudulent orders had been filled, collected and purchased.

None of this really makes sense, Wolfson said Medscape Medical News. “Any doctor who needs Valium doesn’t have to fake a prescription, they can get it from any of their colleagues,” he noted. “And why did you put it in his wife’s name? He also submitted it to his insurance, which leaves more paper trails. And he didn’t need to have insurance for that – Valium is a very cheap drug. “

Further, Wolfson added: “I know people who have been treated by Dr Dattoli and they have nothing but good things to say about him – he is a great doctor with a great bedside manner. is a virgin, he’s never been reprimanded, he’s built a successful practice, and then this thing drops from the sky by parachute. “

The investigation is ongoing and detectives from the Sarasota Police Department have said they “believe there may be other victims.”

Dattoli was released the day after his arrest on $ 1,500 bail. His arraignment is scheduled for January 22. If found guilty, he could face a jail term, fines or even lose his license to practice medicine.

Wolfson added that the arraignment is the first step in the process. “But even if it can be determined that he forged a signature, I don’t think that will reach a level where his license will be revoked,” he said.

To learn more about Medscape Oncology, join us on Twitter and Facebook.

Source link

Local pharmacists fill Rx void as big brands pull out of rural areas Mon, 20 Dec 2021 08:00:00 +0000 [ad_1]

Bill Mather, a pharmacist in the small town of Greenfield, Iowa, wanted to make sure his neighbors could fill their prescriptions without traveling long distances or incurring long wait times.

So when drugstore chains and big-box stores began to expand into rural markets, he sold his drugstore in 2007 to Pamida, a grocery chain owned by department store company Shopko, hoping that it would keep his practice alive. Then, in 2019, when Shopko declared bankruptcy, closing more than 360 stores, he and another Shopko pharmacist helped open a new pharmacy for the town of about 2,000 people.

Across the country, pharmacists like Mather are filling the voids left by the withdrawal of large drugstore chains and big-box stores with pharmacies from small communities. In some areas, pharmacists who were laid off when large chains closed are now opening new pharmacies, often in the same locations. In other regions, owners of pharmacies in neighboring towns are opening new branches. Without them, many communities would have been left without a pharmacy.

It wasn’t like this before. Big-box stores like Shopko began aggressively pushing into the drugstore market 30 years ago, hoping customers would fill their carts while the store filled their prescriptions. Large chains have established footholds in small towns by acquiring independent pharmacies or driving them out of business.

Pharmacist Rachel Hall assists customers at NuCara Pharmacy in Greenfield, Iowa. When a Shopko store – and the last pharmacy in the town of about 2,000 people – closed, patients had to scramble to find places to fill their prescriptions until the NuCara opened. (Kathryn Gamble for KHN)

According to the Bureau of Labor Statistics, the number of pharmacists employed in big box stores peaked at more than 31,800 in 2012. But as online sales and mail delivery of consumer goods and drugs on orders were increasing, the big box stores had no reason to stay. By 2019, the number of big-box pharmacists had fallen to less than 18,000. (The bureau no longer reports the number.)

“Big box stores have entered smaller and smaller communities, and in essence they’ve outperformed every other pharmacy in the area,” said David Zgarrick, professor of pharmacy at Northeastern University in Boston. “Now they are completely gone and with them the pharmacy services and everything they used to provide. They left a void in many of these places.

With CVS Health’s recent announcement that it will be closing 300 stores per year for the next three years, more cities could lose another tier of pharmacies: large drugstore chains. CVS has not yet specified which stores will close.

“We consider a number of factors when making these decisions, including local market dynamics, population shifts, store density and the needs of underserved communities,” said Mike DeAngelis, gatekeeper. word of CVS Health. “In fact, reaching underserved populations has been a priority for us throughout the pandemic, like access to the tests and vaccines we have provided.”

Kathleen Bashur, spokesperson for the National Association of Chain Drug Stores, said pharmacy chains of all types and sizes play an important role in meeting the health and wellness needs of communities across the country. country. “The decision to close a store is difficult,” she said.

Zgarrick attributes much of the decline in big-box pharmacies to Amazon and other online merchants that have undermined the profitability of their non-pharmaceutical sales. In the past, big box stores could treat drugstores as loss leaders and offset that revenue with the sale of other products. Now, Zgarrick said, big box stores have to ask themselves tough questions about how to allocate their space: “’At the end of the day, how are we going to make the most money per square foot? Is it by having a pharmacy or by selling tires? »

Nelson Lichtenstein, a history professor at the University of California, Santa Barbara who has chronicled the rise of Walmart, said big box stores are constantly reassessing their store locations, closing less profitable and opening new ones in places where they think they can make money.

“They just keep kind of a slow churn,” he said.

The cost to build a big-box store is about $10 million, Lichtenstein said, and those stores can generate $200 million in annual revenue. Pulling out of a site is therefore not a huge loss for a large company if revenue declines.

“So they’re going to close the stores and leave a town devastated because Walmart put the other guys out of business,” he said.

Walmart did not respond to questions about its closures.

When the Shopko big box store in Greenfield, Iowa closed, its drugstore records were sold to a Walgreens 50 miles away, leaving the town’s roughly 2,000 residents with no easy way to get their medicine. (Kathryn Gamble for KHN)

The growth of online options for all kinds of items, spurred by home shopping during the covid-19 pandemic, has put additional pressure on big-box stores.

“Now they’re less likely to make those purchases on the go than they were five years ago,” said Adam Hartung, business strategy consultant at Spark Partners. “They’re not going to say, ‘Oh, let’s get a prescription and, while we’re at it, walk around the store and look at the vacuum cleaners. It doesn’t happen anymore.

Hartung said the US retail market has an excess of stores, up to 40% compared to other countries, and more big box stores are expected to close in the coming years.

But the closures offer opportunities for regional chains or pharmacists willing to strike out on their own.

In Orofino, Idaho, the mayor, the chamber of commerce and many residents called on pharmacist Rod Arnzen after Shopko pulled out. So Arnzen began delivering to Orofino from his store 23 miles away in Kamiah. He then opened a branch in Orofino in the building left by the pharmacy that had previously sold its business to Shopko.

Andy Pottenger, who owns a pharmacy 45 miles away in Lewiston, Idaho, added a second pharmacy in Orofino, which has a population of about 3,000, after receiving hundreds of responses to an ad he placed in the local newspaper for assess interest.

“It was overwhelming,” he said. “It kind of cemented the idea that we should do it.”

In Montana, Mike Matovich, a third-generation pharmacist, opened stores in Roundup and Hardin after Shopko closed.

“It’s a pretty big community and there’s a hospital and a clinic in town,” Matovich said of Roundup, “and all of a sudden people are driving 50 miles one way to fill an antibiotic for a kid sick.”

Matovich has seen what can happen when a rural community loses its only pharmacy.

“If there’s a hospital clinic and a pharmacy there, they’ll do pretty well,” Matovich said. “Once you lose one or the other, communities start to struggle because people start leaving to be closer to health care.”

For the residents of Greenfield, Iowa, Shopko’s decision meant they had to scramble. Shopko had sold the pharmacy records to a Walgreens 50 miles away. Some people have turned to Hy-Vee grocery stores in neighboring Iowa towns Atlantic or Winterset, or Walmart in Creston, each at least a half-hour away. Others have gone to mail order.

Pharmacist Rachel Hall was seven months pregnant when she learned that her employer, Shopko, was closing its big box store in Greenfield, Iowa, leaving her jobless and the town without a pharmacy. (Kathryn Gamble for KHN)

“It was pure chaos,” said former Shopko pharmacist Rachel Hall. “People were trying to figure out what to do, where to send their prescriptions.”

Mather, Hall and the rest of the Greenfield staff were only given a week’s notice after being told they had nothing to worry about. Their pharmacy was among the fastest growing locations in the chain.

“We literally had Shopko trophies that we threw away when we left,” Hall said.

Former Shopko executives contacted by KHN declined interview requests. Shopko Optical, which operates in 11 states, said it is no longer affiliated in any way with Shopko Stores and declined to comment.

Mather and Hall did not want to abandon Greenfield. They contacted NuCara, a chain of 30 retail pharmacies in five states, and he agreed to help them open a pharmacy in their city.

NuCara opened pharmacies in two other communities that Shopko left. In the towns of Cokato and North Branch of Minnesota, NuCara partnered with pharmacists who had previously sold their pharmacies to Shopko, said Brett Barker, vice president of pharmacies for NuCara.

In Greenfield, Hall and Mather weren’t allowed to speak to customers at the new NuCara pharmacy until Shopko officially closed. Hall said Shopko management wanted to retain the value of the customer files it sold to Walgreens. So Hall and Mather asked the local chamber of commerce to spread the word.

They found temporary space at the local hospital, which moved its billing office to accommodate them. A year later, they moved back to their old location in the old Shopko building, leasing the space to new owners, who operated a housewares store there.

After serving three generations of Greenfield customers, Mather was relieved the town still had a pharmacy. But he couldn’t forget how Shopko ended things.

“The way they slammed the door, I was really unhappy with that,” Mather said. “It wasn’t fair to all the people at Greenfield Pharmacy and the people of Greenfield. Shopko couldn’t care less.

Still, the move has come full circle for Mather. Greenfield still has a pharmacy, like when he started at Murdy Drug in 1968. It’s just a different storefront, with a new name on the sign.

NuCara Pharmacy in Greenfield, Iowa, moved to the former space of a Shopko drugstore a year after the Shopko big-box chain closed its store there and all of its locations across the country. (Kathryn Gamble for KHN)

Related Topics

Contact us Submit a tip

Source link

The local store sells a variety of herbal medicine products | Business Sun, 11 Oct 2020 07:00:00 +0000 [ad_1]

Akasha’s Treasures, located at 1408 Edgefield Street in Killeen, sells all kinds of things such as herbs, herbal teas, bath products, and even spices for everyday use.

“I opened my business in this area in 2006,” said owner Charletha Johns. “The location I have now has been open for eight years and before that I had been doing it for a year and a half on Clear Creek (Road). In fact, I’ve been doing this type of business since the 90s when I lived in Colorado.

Johns said the idea to open the store in the area came from when she was the leader of the family prep group and one of her volunteers asked her how to make candles.

“Her husband actually made websites and I got back into business,” she said. “In my store, we sell 250 herbs, we make over two dozen different herbal teas, it’s like a homeopathic medicine. We don’t tell anyone to stop taking medication, but we have alternatives. My prices range from 10 cents to 1,500 dollars.

Johns said she also sells all-natural oils and a full line of all natural bath products.

“I sell candles and decorative gifts,” she said. “They’re all made here. I also make my own seasonings and since they are fresh they are only on the shelves for a week or two whereas in stores they can be there for years. I grow some of my own herbs here and some are from a supplier in Iowa.

Some of the store’s biggest sellers are herbal medicines, Johns said.

“Graviola Soursop, Moringa and Maca where you can make it into a tea or a food I made,” she said. “We also have herbs like marjoram, thyme and acai.”

Johns said his company currently has five employees in the store.

“We explain our products,” she said, “We don’t practice black magic, we don’t believe in it, and we don’t practice it at all. I also have an online business where I donate to suppliers for their business and ships worldwide. We are open Monday to Friday 10am to 7pm but when it gets darker we will close at 6.30pm on Saturday we are open 10am to 6.30pm and Sunday 11am to 5.30pm ”

Source link

]]> 0